<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Gregory E</submitter><funding>National Cancer Institute</funding><funding>NCI NIH HHS</funding><funding>Pharmaceutical Research and Manufacturers of America Foundation</funding><funding>National Institute of General Medical Sciences</funding><funding>NIGMS NIH HHS</funding><funding>Arkansas Biosciences Institute</funding><pagination>45-58</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC11950487</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>4(1)</volume><pubmed_abstract>&lt;h4>Purpose&lt;/h4>Pancreatic ductal adenocarcinoma (PDAC) remains a leading cause of cancer-related deaths, and perineural invasion (PNI), in which cancer cells infiltrate nerves, enables metastasis in most patients. PNI is largely attributed to Schwann cells (SC) that, when activated, accelerate cancer cell migration towards nerves. However, this cancer-associated reprogramming is generally under-appreciated. Additionally, tumor extracellular vesicle (EV) facilitation of cancer aggravation is well documented, but more investigation is required to better understand their role in PNI. Here, we assessed whether PDAC EVs mediate PNI via SC activation using tissue-engineered in vitro platforms and PANC-1 and HPNE human cell lines as models.&lt;h4>Methods&lt;/h4>NanoSight, Luminex®, and proteomic-pathw</pubmed_abstract><journal>In vitro models</journal><pubmed_title>Pancreatic cancer extracellular vesicles stimulate Schwann cell activation and perineural invasion in vitro via IL-8/CCL2.</pubmed_title><pmcid>PMC11950487</pmcid><funding_grant_id>P20 GM139768</funding_grant_id><funding_grant_id>R24 GM137786</funding_grant_id><funding_grant_id>R24GM137786</funding_grant_id><funding_grant_id>R37 CA279722</funding_grant_id><funding_grant_id>P20GM139768</funding_grant_id><funding_grant_id>R37CA279722</funding_grant_id><pubmed_authors>Powers I</pubmed_authors><pubmed_authors>Griffin RJ</pubmed_authors><pubmed_authors>Gregory E</pubmed_authors><pubmed_authors>Jamshidi-Parsian A</pubmed_authors><pubmed_authors>Song Y</pubmed_authors></additional><is_claimable>false</is_claimable><name>Pancreatic cancer extracellular vesicles stimulate Schwann cell activation and perineural invasion in vitro via IL-8/CCL2.</name><description>&lt;h4>Purpose&lt;/h4>Pancreatic ductal adenocarcinoma (PDAC) remains a leading cause of cancer-related deaths, and perineural invasion (PNI), in which cancer cells infiltrate nerves, enables metastasis in most patients. PNI is largely attributed to Schwann cells (SC) that, when activated, accelerate cancer cell migration towards nerves. However, this cancer-associated reprogramming is generally under-appreciated. Additionally, tumor extracellular vesicle (EV) facilitation of cancer aggravation is well documented, but more investigation is required to better understand their role in PNI. Here, we assessed whether PDAC EVs mediate PNI via SC activation using tissue-engineered in vitro platforms and PANC-1 and HPNE human cell lines as models.&lt;h4>Methods&lt;/h4>NanoSight, Luminex®, and proteomic-pathw</description><dates><release>2025-01-01T00:00:00Z</release><publication>2025 Feb</publication><modification>2025-07-12T03:04:17.307Z</modification><creation>2025-07-12T03:04:17.307Z</creation></dates><accession>S-EPMC11950487</accession><cross_references><pubmed>40160208</pubmed><doi>10.1007/s44164-025-00083-w</doi></cross_references></HashMap>